MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0012285
Kaiway Pharmaceuticals Private Limited
Kaiway Pharmaceuticals Private Limited - manufacturing in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14,585
▼ 37% YoY
Net loss · FY 2025
₹13,540
Net margin -92.8%
EBITDA · FY 2025
-₹11,520
EBITDA margin -79%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Kaiway Pharmaceuticals Private Limited
Data last updated:
Kaiway Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing sector. It was incorporated on 05 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33200DL2021PTC376571. Its GSTIN is 07AAICK5950A1ZP (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kailashi Devi and Praveen Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 37 Block – G Pkt 3 Sec 16 Rohini, Delhi, India – 110089.
As per the financials filed for FY 2025, the company reported a revenue of ₹14,585, a decline of 37% compared to the previous year. For the same year it recorded a net loss of ₹13,540 (net margin -92.8%) and EBITDA of -₹11,520 (EBITDA margin -79%).
Kaiway Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0012285).
Company details
CIN U33200DL2021PTC376571
Registration Number 376571
Incorporation Date 05 February 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0012285
Key People
Kailashi Devi Director Praveen Kumar Director Recognitions & Rankings of Kaiway Pharmaceuticals
Contact details
Kaiway Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 37 Block – G Pkt 3 Sec 16 Rohini, Delhi, India – 110089
- IndustryManufacturing, Manufacturing, Optical & Photographic Instruments
To see the full contact details of Kaiway Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kaiway Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kaiway Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kaiway Pharmaceuticals Private Limited, buy the company report.
Financials of Kaiway Pharmaceuticals Private Limited
FY 2025 filings availableKaiway Pharmaceuticals Private Limited reported revenue of ₹14,585 (down 37% YoY) for FY 2025.
Revenue · FY 2025
₹14,585 ▼ 37%
Net loss · FY 2025
₹13,540 margin -92.8%
EBITDA · FY 2025
-₹11,520 margin -79%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 37%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 15%
Revenue fell 37% in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11,520 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13,540 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -79% | ||||
| Net Profit Margin | -92.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kaiway Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kaiway Pharmaceuticals Private Limited
Kaiway Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kailashi Devi | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
| Praveen Kumar | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Kaiway Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kaiway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kaiway Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
Kaiway Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICK5950A1ZP | Delhi | Active | 25 Dec 2021 |
To see the full GST registrations and return filing status of Kaiway Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kaiway Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Kailashi Devi was appointed as Director on 05 Feb 2021.
AGM
Kaiway Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kaiway Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Kailashi Devi was appointed as Director.
Appointed
Praveen Kumar was appointed as Director.
Incorporation
05 Feb 2021
Kaiway Pharmaceuticals Private Limited was registered on 05 Feb 2021 with Roc Delhi I & aged 5 years 8 months as per MCA records.
Frequently asked questions
Kaiway Pharmaceuticals is an active private limited company based in Delhi, India. The company works in the manufacturing industry. It was incorporated on 05 February 2021 (5+ years old) and is registered under CIN U33200DL2021PTC376571.
Kaiway Pharmaceuticals has 2 current directors:
- Kailashi Devi - Director
- Praveen Kumar - Director
The latest financial statements of Kaiway Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Kaiway Pharmaceuticals is 07AAICK5950A1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Kaiway Pharmaceuticals is U33200DL2021PTC376571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kaiway Pharmaceuticals was incorporated on 05 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Kailashi Devi was appointed as Director on 05 Feb 2021. Praveen Kumar was appointed as Director on 05 Feb 2021.
Yes, Kaiway Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0012285).
The registered office of Kaiway Pharmaceuticals is at House No. 37 Block – G Pkt 3 Sec 16 Rohini, Delhi, India – 110089.
Kaiway Pharmaceuticals operates in the manufacturing industry.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages